Bruker Corp (BRKR)
70.71
-8.23
(-10.43%)
USD |
NASDAQ |
May 02, 09:32
Bruker Total Assets (Quarterly): 4.250B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.250B |
September 30, 2023 | 3.820B |
June 30, 2023 | 3.857B |
March 31, 2023 | 3.764B |
December 31, 2022 | 3.612B |
September 30, 2022 | 3.337B |
June 30, 2022 | 3.385B |
March 31, 2022 | 3.551B |
December 31, 2021 | 3.65B |
September 30, 2021 | 3.128B |
June 30, 2021 | 3.087B |
March 31, 2021 | 3.035B |
December 31, 2020 | 3.049B |
September 30, 2020 | 2.879B |
June 30, 2020 | 2.943B |
March 31, 2020 | 2.962B |
December 31, 2019 | 2.772B |
September 30, 2019 | 2.352B |
June 30, 2019 | 2.350B |
March 31, 2019 | 2.242B |
December 31, 2018 | 2.129B |
September 30, 2018 | 1.889B |
June 30, 2018 | 1.806B |
March 31, 2018 | 1.830B |
December 31, 2017 | 1.948B |
Date | Value |
---|---|
September 30, 2017 | 1.962B |
June 30, 2017 | 1.913B |
March 31, 2017 | 1.840B |
December 31, 2016 | 1.808B |
September 30, 2016 | 1.798B |
June 30, 2016 | 1.720B |
March 31, 2016 | 1.740B |
December 31, 2015 | 1.73B |
September 30, 2015 | 1.843B |
June 30, 2015 | 1.820B |
March 31, 2015 | 1.773B |
December 31, 2014 | 1.865B |
September 30, 2014 | 1.911B |
June 30, 2014 | 2.004B |
March 31, 2014 | 2.028B |
December 31, 2013 | 1.988B |
September 30, 2013 | 1.936B |
June 30, 2013 | 1.802B |
March 31, 2013 | 1.812B |
December 31, 2012 | 1.856B |
September 30, 2012 | 1.80B |
June 30, 2012 | 1.750B |
March 31, 2012 | 1.797B |
December 31, 2011 | 1.710B |
September 30, 2011 | 1.670B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.350B
Minimum
Jun 2019
4.250B
Maximum
Dec 2023
3.252B
Average
3.128B
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
Azenta Inc | 2.824B |
Harvard Bioscience Inc | 137.37M |
Bionano Genomics Inc | 214.40M |
Akoya Biosciences Inc | 180.37M |
Singular Genomics Systems Inc | 265.47M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 2.837B |
Shareholders Equity (Quarterly) | 1.377B |
Debt to Equity Ratio | 0.9305 |
Current Ratio | 1.800 |
Net Debt Paydown Yield | -0.24% |